Association of Spermatogenic Failure with the b2/b3 Partial AZFc Deletion by Eloualid, Abdelmajid et al.
Association of Spermatogenic Failure with the b2/b3
Partial AZFc Deletion
Abdelmajid Eloualid
1,5*, Houria Rhaissi
5, Ahmed Reguig
1, Safaa Bounaceur
1, Brahim El houate
1,
Omar Abidi
1, Majida Charif
1, Noureddine Louanjli
3, Elbakkay Chadli
2, Abdelhamid Barakat
1,
Anu Bashamboo
4, Ken McElreavey
4, Hassan Rouba
1
1Human Genetic Unit, Research Department, Pasteur Institute, Casablanca, Morocco, 2Cytogenetic Unit, Pasteur Institute, Casablanca, Morocco, 3LABOMAC Laboratory,
Casablanca, Morocco, 4Human Developmental Genetics Unit, Pasteur Institute, Paris, France, 5Faculty of Sciences Ben M’sik, Casablanca, Morocco
Abstract
Infertility affects around 1 in 10 men and in most cases the cause is unknown. The Y chromosome plays an important role in
spermatogenesis and specific deletions of this chromosome, the AZF deletions, are associated with spermatogenic failure.
Recently partial AZF deletions have been described but their association with spermatogenic failure is unclear. Here we
screened a total of 339 men with idiopathic spermatogenic failure, and 256 normozoospermic ancestry-matched men for
chromosome microdeletions including AZFa, AZFb, AZFc, and the AZFc partial deletions (gr/gr, b1/b3 and b2/b3). AZFa
and AZFc deletions were identified in men with severe spermatogenic failure at similar frequencies to those reported
elsewhere. Gr/gr deletions were identified in case and control populations at 5.83% and 6.25% respectively suggesting that
these deletions are not associated with spermatogenic failure. However, b2/b3 deletions were detected only in men with
spermatogenic failure and not in the normospermic individuals. Combined with our previous data this shows an association
of the b2/b3 deletion (p=0.0318) with spermatogenic failure in some populations. We recommend screening for this
deletion in men with unexplained spermatogenic failure.
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Introduction
Infertility is defined as the inability to conceive or produce an
offspring after one year of unprotected intercourse [1]. It is
estimated that infertility affects 10–15% of couples, and roughly
half of these cases are due to the male partner [2]. The
identification and classification of male infertility requires semen
analysis, obtained on at least two separate occasions, and reported
according to standard reference values set out by the World
Health Organization (1992). Sperm disorders are the most
common cause of male factor infertility [3]. Infertile men can
present with azoospermia, oligozoospermia, asthenozoospermia,
teratozoospermia or by any combination of these.
There are several genes on the Y chromosome necessary for
spermatogenesis [4]. Tiepolo and Zuffardi in 1976 identified
deletions of the long arm of the Y chromosome associated with
spermatogenic failure [5]. Subsequently these deletions were
characterised in the euchromatic part of the long Y arm and
designated as AZoospermia Factors (AZFa, AZFb and AZFc) [6].
These regions contain several genes or gene families that are
expressed in the testis and involved in spermatogenesis [7].
Complete deletions of AZFa, AZFb or AZFc regions are usually
accompanied with different histopathological profiles; the AZFa
region contains the genes USP9Y and DBY (also called DDX3Y),
Protein-encoding gene families on the AZFb region include
RBMY, PRY, and CDY2 which are expressed only in the testis.
The complete AZFc region contains eight gene families (DAZ,
BPY2, CDY1, CSPG4LY, GOLGA2LY, TTTY3, TTTY4, and
TTTY17), five of which 5 are expressed only in the testis [4,5].
Deletions affecting the AZFa region are associated with Sertoli cell
only type I syndrome (SCOS type I) that is characterized by the
total absence of germ cells in seminiferous tubules and associated
with non-obstructive azoospermia. Deletions of the complete
AZFb region are usually associated with meiotic arrest, whereas
complete deletions of AZFc are associated with variable
phenotypes including a significant reduction in sperm count and
progressive decline in semen quality [8]. Finally, large deletions
that encompass either AZFb+c or AZFa+b+c are associated with a
lack of testicular sperm. The most frequently deleted region is
AZFc (approximately 60% of cases), followed by deletions of the
AZFb and AZFb+c or AZFa+b+c regions (35%), while isolated
AZFa deletions are rare (5%) [9].
The precise functional contribution of each of these genes and
transcription units to spermatogenesis is unknown [10]. Recently
several types of AZFc partial deletions had been identified
including the gr/gr, b2/b3 and b1/b3 subdeletions [11]. The
relationship between these AZF subdeletions and spermatogenic
failure is unclear. The gr/gr deletion is the most commonly
detected, indeed, the prevalence of gr/gr deletions varied from 2.1
to 12.5% among all cases, and from 0 to 10.2% among
normozoospermic controls [11]. This deletion removes half of
the AZFc region including two copies of the DAZ gene family
(DAZ1/DAZ2), one copy of the CDY1 gene family (CDY1a) and one
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risk factor for reduced sperm counts although not all studies have
identified such an association [13]. Gr/gr deletions are in fact a
group of different deletions caused by recombination between the
amplicons g1/g2, r1/r3 and r2/r4 [12,14,15].
The b2/b3 deletion removes 1.8 Mb of AZFc and appears to be
a polymorphism without an obvious effect on fertility, despite the
absence of a number of AZFc genes. The b2/b3 deletion is derived
from a gr/rg inversion or b2/b3 inversion [10,16]. The association
of the b2/b3 partial deletion with male infertility has been
reported in Chinese men, whereas no such a predisposition was
detected in other populations [10,16,17,18,19,20]. The b1/b3
deletion is rare and its frequency varies amongst populations with
only 18 deletions published to date [12,21–23]. Because this
deletion has a much lower frequency than the gr/gr deletion, its
effect on spermatogenesis is unkown [16].
Our objective was to determine the prevalence of different
forms of AZF microdeletions, to evaluate their association with
spermatogenic failure, and to define genetic association between
the partial AZFc deletions in a well-defined case and control
population.
Materials and Methods
Subjects
This study populations consisted of 339 men with spermato-
genic failure and 256 normozoospermic men. All patients and
controls were of Moroccan ancestry. Selection criteria were
stringent; Ejaculates were obtained by masturbation after 2–7 days
of sexual abstinence. All underwent an andrological work-up,
which included medical history, physical examination, hormonal
evaluation (FSH, LH, and testosterone) and semen analysis. Men
with known clinical (cryptorchidism, infections, varicocele) or
genetic (karyotype anomalies) causes of infertility were excluded.
The normospermic men were selected from couples attending
infertility clinics in the Casablanca region over a period of 12
years. These men had $20610/ml sperm concentration,
$406106 total sperm count, $2 ml semen volume, $50% of
a+bo r$25% a motility, high percentage of normal forms ($10%)
with normal spermatogenesis according to WHO criteria. The
infertility in these couples was due to female factors and/or these
men had previously induced a spontaneous pregnancy in the
current or a former relationship.
On the basis of repeated semen analyses and World Health
Organization criteria the men with idiopathic spermatogenic
failure were divided into 2 groups (Table 1). We obtained written
informed consent from each subject and the study protocol was
approved by the Committee on Research Ethics of Institut Pasteur
du Maroc.
Y chromosome microdeletions analysis. Genomic DNA
was extracted from peripheral leukocytes by standard means of
proteinase K digestion followed by phenol–chloroform extraction
and ethanol precipitation.
In order to confirm the specific relationship with spermatogen-
esis, we analysed the classical AZFa, AZFb and AZFc deletion in
all patients and controls, two multiplex PCR systems (A and B)
were carried out according to the European Academy of
Andrology/European Molecular Genetics Quality Network
(EAA/EMQN) guidelines [24]. Each of these subjects was tested
for six AZF loci: the STS primers used for AZFa (sY84, sY86),
AZFb (sY127, sY134) and AZFc (sY254, sY255). The internal
control used was SRY14, samples from normal fertile men,
without Y chromosome microdeletions and from healthy women,
were used as normal controls, blank served as negative control.
The samples, in which the deletions were detected, were
confirmed by repeating the PCR analysis at least three times.
Screening for partial AZFc deletions. Patients without
classical AZFa, AZFb and AZFc microdeletions and all control
subjects were screened for partial AZFc deletions. The presence
or absence of the AZFc partial deletions in all subjects was tested
by PCR using genomic DNA, amplifying STS markers [25]. The
STSs were sY1191, sY1291, sY1206, sY1197, sY1258 and
sY1201. A gr/gr deletion was identified by the absence of
marker sY1291 and presence of other STSs. The b2/b3 deletions
were characterized by the absence of the STS sY1191 and the
presence of other STSs. The absence of markers sY1291, sY1191
and sY1197 combined with the presence of others indicated the
b1/b3 deletion.
Y chromosome haplotypes analysis. Samples were
genotyped for Y chromosome binary markers that are infor-
mative for North African populations. These were M35 (E3B),
M81 (E3b2), 12f2a (J), M173 (R), and M89 (F). The Y genealogy
used is based on that published by the Y Chromosome
Consortium [26].
Statistical analysis. Differences among frequencies were
calculated using the chi square (x
2)-test or Fisher’s exact test, all p-
values were based upon two-tailed tests and Odds ratios (ORs),
95% confidence intervals (CIs) were carried out, and P
values,0.05 were taken as statistically significant.
Results
Screening for classical AZF microdeletions
In total, 13 out of the 339 infertile men (3.83%) with
spermatogenesis impairment were found to have classical AZF
deletions using STS analysis of genomic DNA (Table 1). These
cases included one AZFa deletion, two AZFb+c deletions and two
AZFa+b+c found in azoospermia patients and 8 AZFc deletions
associated with 3 cases of azoospermia and 5 cases of severe
oligozoospermia. No microdeletions were found in the normo-
zoospermic controls.
Screening for partial deletions of AZFc region
After excluding 13 patients with AZF deletions, we evaluated
the distributions of partial AZFc deletions in 326 infertile patients
and 256 normozoospermic men. We found three types of partial
AZFc deletions in patients (Table 1); 19 (5.82%) gr/gr, 4 (1.22%)
b2/b3 and 2 (0.61%) b1/b3 deletions. In contrast, screening of
256 control men revealed 16 (6.25%) gr/gr partial deletions and
no b2/b3 nor b1/b3 deletions.
Y chromosome haplogroups
Of the 41 patients carrying partial AZFc deletions sufficicent
DNA was available for determining the Y chromosome hap-
logroup in 31 cases (Table 1). The distribution of haplogroups was
not significantly different between the case and control popula-
tions. The high frequency of E3b2 chromosomes is consistent with
previous studies of Moroccan populations where 80% of
chromosome carry this marker [27,28].
Discussion
Classical AZF deletions, defined by a few well-designed markers
[24], are clinically relevant because a clear cause–effect relation-
ship between these deletions and spermatogenic failure has been
established [29–32]. In this study, the overall frequency of AZF
microdeletions was 3.83% in infertile men of Moroccan ancestry.
This prevalence is similar to the first study in Moroccan
Infertility and Partial AZFc Deletion
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reported by other studies which range from 3% to 55% [1,34,35].
The prevalence of AZF microdeletions in patients with azoosper-
mia and severe oligozoospermia was 9.09% and 5.49%,
respectively. This incidence is similar to other reports describing
a prevalence of AZF microdeletions in the range of 4.25% to 23%
and 0.1% to 8.5% in patients with non-obstructive azoospermia
and severe oligozoospermia respectively [36–38].
In our study only a single AZFa deletion was present and
deletions were not detected in the AZFb region. Using an STS
based approach we identified three types of partial AZFc deletion,
gr/gr, b2/b3 and b1/b3. The gr/gr group of deletions was present
in patient and control cohorts at similar frequencies of 5.83% and
6.25% respectively.. This result is similar to several studies that
have not detected an association between the gr/gr deletion and
failure of spermatogenesis [18,19,32,39,40]. The frequency of the
gr/gr deletion varies on different Y chromosome backgrounds.
The gr/gr deletion was initially observed in 14/43 different Y
haplogroups suggesting that this deletion has occured several times
during human evolution [12]. In one Y chromosome haplogroup
that is common in men of Japanese origin, D2b, all samples
studied carried the gr/gr deletion suggesting that the deletion is
fixed in this haplogroup [12]. In our study the gr/gr deletions were
present on different Y chromosome haplogroups indicating
multiple deletion events and, in 80% of cases, it was present on
the E3b2 haplogroup. Although this is suggestive of a high
frequency of gr/gr deletion within this haplogroup, it should be
noted that haplogroup E3b2 is present at high frequencies (80–
85%) in the general North African population [27,28]. It is
important to note that gr/gr deletions are not a homogenous
group of rearrangements within the AZFc region [25]. The
various subclasses of gr/gr deletions show variation in gene loss
and may be associated with other complex rearrangements such as
duplications and inversions [25]. It is formally possible that the gr/
gr deletions that we have identified in our case and control
population may belong to distinct subclasses that could have an
impact on spermatogenesis.
In contrast, the partial deletions b2/b3 and b1/b3 were present
only in the infertile patient cohort. The b2/b3 deletion was found
in 4 patients with severe oligoastheno-teratozoospermia, further-
more the b1/b3 deletion was presented in 2 patients, one with
azoospermia and the other with oligoastheno-teratozoospermia.
We have previously reported these deletions in the Moroccan
population [33]. Including the data from our previous study we
have now identified 6/475 infertile men carrying the b2/b3
deletion (p=0.0318) and 2/475 infertile men carrying the b1/b3
deletion (p=0.5006). These deletions were not observed in the 432
control samples.
The b2/b3 deletion was originally reported at high frequencies
in northern Eurasian populations where it is fixed on the Y
chromosome haplogroup N suggesting a founder mutation [16].
This haplogroup is the majority haplogroup in some Baltic
populations and it does not appear to have an effect on
reproductive fitness [16]. However, the b2/b3 deletion shows a
strong association with idiopathic male infertility in the Han
Chinese population [20]. These b2/b3 deletions were present on
different Y chromosome haplogroups than the haplogroup N
found in Northern Eurasian populations. This suggests that
depending on the Y chromosome background the b2/b3 may
have an adverse effect on spermatogenesis or that the b2/b3
deletions actually represent a family of closely related but distinct
deletions that differ in their influence on spermatogenesis. Indeed,
here we observed the b2/b3 deletion on Y chromosome
haplogroups E3b2 and J.
Based on these observations we would recommend screening for
b2/b3 deletions in larger cohorts of case and control populations
of different ethnic/geographic origins to further understand the
contribution of b2/b3 deletions to male infertility.
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